Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.

@article{Rugani2010BisphosphonateassociatedOO,
  title={Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.},
  author={Petra Rugani and Stephan Acham and Astrid Truschnegg and Barbara Obermayer-Pietsch and Norbert Jakse},
  journal={Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics},
  year={2010},
  volume={110 6},
  pages={e1-6}
}
Bisphosphonates (BP) play an important role in concomitant therapy of certain types of cancer and multiple myeloma as well as in treatment of osteoporosis. The administration of BP has great therapeutic benefits, but correlates with a specific kind of osteonecrosis of the alveolar bone. The so-called bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a rare, but often severe adverse side effect of high-dosage and long-term BP therapy. Thus far, no consensus for treatment of BRONJ has… CONTINUE READING